Hemme, E., Depuydt, M. A., van Santbrink, P. J., Wezel, A., Smeets, H. J., Foks, A. C., . . . Bot, I. (2024). Leukemia inhibitory factor receptor inhibition by EC359 reduces atherosclerotic stenosis grade in Ldlr−/− mice. European journal of pharmacology, 985, 177121. https://doi.org/10.1016/j.ejphar.2024.177121
Citace podle Chicago (17th ed.)Hemme, Esmeralda, Marie A.C Depuydt, Peter J. van Santbrink, Anouk Wezel, Harm J. Smeets, Amanda C. Foks, Johan Kuiper, a Ilze Bot. "Leukemia Inhibitory Factor Receptor Inhibition by EC359 Reduces Atherosclerotic Stenosis Grade in Ldlr−/− Mice." European Journal of Pharmacology 985 (2024): 177121. https://doi.org/10.1016/j.ejphar.2024.177121.
Citace podle MLA (9th ed.)Hemme, Esmeralda, et al. "Leukemia Inhibitory Factor Receptor Inhibition by EC359 Reduces Atherosclerotic Stenosis Grade in Ldlr−/− Mice." European Journal of Pharmacology, vol. 985, 2024, p. 177121, https://doi.org/10.1016/j.ejphar.2024.177121.